相关实验视频
Updated: May 9, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
针对siRNA输送的特定抗体-聚合物合物
Hua Lu1, Danling Wang, Stephanie Kazane
1Department of Chemistry, The Scripps Research Institute , La Jolla, California 92037, United States.
Journal of the American Chemical Society
|August 9, 2013
概括
特定抗体-聚合物结合物 (APC) 有效地将小干扰RNA (siRNA) 传递给HER2阳性细胞以进行基因沉默. 结合部位对于治疗疗效至关重要,影响抗原结合和细胞吸收.
科学领域:
- 生物结合化学 生物结合化学
- 分子治疗学分子治疗学
- 癌症生物学 癌症生物学
背景情况:
- 针对性地提供核酸治疗药物仍然是一个挑战.
- 抗体-聚合物合物 (APC) 提供了针对特定部位的药物递送的潜力.
- HER2阳性癌症是一个重要的治疗点.
研究的目的:
- 开发和表征特定部位的抗体-聚合物合物 (APCs) 用于向siRNA传递.
- 评估结合部位对APC疗效和基因沉默的影响.
- 评估APC作为基于核酸的疗法平台的潜力.
主要方法:
- 使用遗传编码的p-乙氨酸合成抗体-聚合物合物.
- 对APC结合亲和力和细胞细胞毒性的表征.
- 在HER2阳性细胞中siRNA传递和基因沉默的体外评估.
主要成果:
- 抗原抗体表现出与原生抗体相比较的结合亲和力,没有显著的细胞毒性.
- 特定的APC变种成功地将siRNA传递给HER2阳性细胞,调解强大的mRNA和蛋白质水平基因沉默.
- 一个APC变体,尽管具有较高的结合亲和力,但未能诱导基因沉默,突显了结合部位的重要性.
结论:
- 化学定义的APC是针对性siRNA传递的可行平台.
- 抗体上的结合部位显著影响APCs的治疗活性.
- 这些发现强调了合理设计在开发基于抗体聚合物的治疗方法中的重要性.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.